Lupin 2024

mRNA-1273

Moderna announces COVID-19 vaccine deal

Moderna announces COVID-19 vaccine deal

CAMBRIDGE, Mass.— Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people. The award of up to $1.525 billion is for the manufacturing and delivery of 100 million doses of mRNA-1273

PP_1170x120_10-25-21